tixagevimab/cilgavimab
Evusheld is now non-formulary. The EUA has been revoked by the FDA due to lack of activity against circulating COVID-19 variants. (Feb 2023)
Reviewed: December 2021 (Evusheld)
Updated: February 2023 (Evusheld)
Evusheld is now non-formulary. The EUA has been revoked by the FDA due to lack of activity against circulating COVID-19 variants. (Feb 2023)
Reviewed: December 2021 (Evusheld)
Updated: February 2023 (Evusheld)